Executives On The Move
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Arvinas Nabs New Chief Financial Officer From Intercept Pharmaceuticals
Recent moves in the industry include changes at the top for Sumitomo Pharma, ASKA and Takeda, plus Maat Pharma gets a new chief medical officer.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: New Hires At Eisai, Connect Biopharma, Actylis And More
Recent moves in the industry include new chief executive officers at Connect Biopharma, Skyhawk Therapeutics and Actylis, plus I-Mab gets new chief medical officer.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Three New CFOs And One New CEO Among This Week's Changes
Recent moves in the industry include C-suite shuffles at MorphoSys, Centessa Pharmaceuticals and Skyhawk Therapeutics, plus bluebird bio acquires a new chief financial officer.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Assertio Holdings Acquires Chief Executive Officer from Glenmark Pharmaceuticals
Recent moves in the industry include changes at the top for Inhibrx and Monte Rosa Therapeutics, plus Imunon, Avrobio and Kronos Bio acquire chief financial officers from Cyteir Therapeutics, Oyster Point Pharma and Senti Biosciences, respectively.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Eight New C-Suite Appointments Among This Week's Changes
Recent moves in the industry include C-suite shuffles at Cosmo Pharmaceuticals and Nurix Therapeutics, as Cosmo Pharmaceuticals gets a new chief executive officer.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Ocular Therapeutix Hooks ChIef Medical Officer From Beacon
Recent moves in the industry include C-suite shuffle at Senti Biosciences, plus BioMarin Pharmaceutical gets new chief commercial officer.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Viracta Therapeutics Acquires Chief Fincancial Officer From Harpoon
Recent moves in the industry include new chief scientific officer at Wave Life Sciences, while Alliance Pharma gets a new CEO.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Senior Moves At ALX Oncology, Aprea And PDS
Recent moves in the industry include new CEOs at Juno Pharmaceuticals and YS Biopharma, plus Glenmark gets a new chief communications officer.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Senior Moves At Innovent Biologics, Actym Therapeutics And Enanta Pharmaceuticals
Recent moves in the industry also include C-suite shuffles at Faron Pharmaceuticals and new chief financial officers at Orion, BioVaxys Technology and Cullinan Therapeutics.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Three New CEOs Among This Week's Changes
Recent moves in the industry include new chief executive officers at Medisca, Anthos Therapeutics and Systimmune.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Three New CMOs And CFOs Among This Week's Changes
Recent moves in the industry include C-suite shuffles at PureTech Health and Traws Pharma, plus Xencor gets a new chief financial officer.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Hookipa Hooks Development Head From Evotec
Latest moves in biopharma leadership include Mark Winderlich becoming chief development officer at Hookipa Pharma and Dianne Hol leaving AstraZeneca to join Lundbeck, where she becomes EVP people and organization.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
![](/-/media/editorial/buildings/corporate/b/bayer-1200-shutterstock_2194521065.jpg?rev=c33f499461a344d2ada99d9b6c6085ee&w=350&hash=D8E35E997A651D6E956F509ED5401A08)
Bayer’s New Pharma Leader To Spearhead Growth From US
The troubled conglomerate is accelerating its moves to streamline its business, with the creation of a more customer- and US-focused pharma division.
![](/-/media/editorial/scrip/00_regular-column-images/sc2107_executives_on_the_move_2c3p31h_1200.jpg?rev=ddb459a9ab26479eb6ba6d7a3f80a977&w=350&hash=5AD4A7BF388B857671291EE5A6F9FF38)
Executives On The Move: New Hires At Everest Medicines, Arvinas, Fulcrum Therapeutics And More
Recent executive changes in the industry include seven new chief medical officers, and new chief commercial officers at Adaptimmune Therapeutics and Syndax Pharmaceuticals.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.